Delivery Order SPE2DB20D2014-SPE2DB24FC85N
Award Date
8/26/24
Potential Completion Date
8/27/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of QULIPTA 60 MG TABLET 30S. The $11,274.39 firm fixed-price delivery order was awarded on September 16, 2024, with a completion date of September 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $6,956.59 and a period of performance through January 2, 2025. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,863.87 Firm Fixed Price delivery order contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,354.10 firm fixed-price delivery order contract provides QULIPTA 60 MG TABLET 30S, a pharmaceutical product, to support the DLA's medical supply requirements. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,999.07 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,302.13 firm fixed-price delivery order is for the provision of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,272.50 firm fixed-price delivery order contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. It was not designated as a set-aside contract....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,677.90, is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 15, 2024. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,153.06 firm fixed-price delivery order is for the QULIPTA 60 MG TABLET 30S medical product, with a completion date of July 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,235.74 firm fixed-price delivery order contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...